跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Co-Diovan - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Co-Diovan
Approved
STANDARD
Co-Diovan
Novartis Farma S.p.A
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
11c2a400adc1cd38
Company
Novartis Farma S.p.A
Type
Standard
Approval Details
Approval Id
11c2a400adc1cd38
Drug Approval Philippines Name
Co-Diovan
Product Name
Co-Diovan
Registration Number
DRP-7650
Brand Name
Co-Diovan
Generic Name
Valsartan + Hydrochlorothiazide
Dosage Form
Tablet
Dosage Strength
320 mg/25 mg
Manufacturer
Novartis Farma S.p.A
Importer
Novartis Healthcare Philippines, Inc.
Distributor
Novartis Healthcare Philippines, Inc.
Issuance Date
26 March 2023
Expiry Date
11 March 2028
Pharmacologic Category
Angiotensin II Receptor Blocker + Diuretic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
11c2a400adc1cd38
Type
Standard
Back to Philippines FDA Approvals